Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Kapa Biosystems Extends Exclusive Japanese Distribution Agreement with Nippon Genetics

Published: Monday, August 04, 2014
Last Updated: Friday, August 08, 2014
Bookmark and Share
Latest agreement builds on continued commercial success of Kapa’s genomics product portfolio over the past seven years in the Japanese market.

Kapa Biosystems has signed a new three-year exclusive distribution agreement with Nippon Genetics Co., Ltd., further extending the successful seven-year relationship between the companies and enabling Nippon Genetics to continue marketing, distributing, and servicing Kapa Biosystems’ genomics reagents in Japan. This agreement is a key part of Kapa Biosystems corporate growth strategy and the first of several key commercial announcements that will be made later this year.

Kapa Biosystems offers a portfolio of advanced reagents for use in PCR, qPCR, next-generation sequencing, and molecular diagnostics applications. The reagents contain novel enzymes—engineered via directed evolution—that confer significant performance advantages when compared to traditional wild-type enzymes. Many of the products are optimized for challenging samples and high-throughput workflows, and include pre-validated scripts using the leading liquid-handling automation platforms.

“The genetic research and applied markets in Japan are growing exponentially and many scientists rely on us to deliver high-quality and reliable solutions,” said Kazuo Yamazaki, CEO and President, Nippon Genetics Co., Ltd. “Kapa Biosystems products fit perfectly within our innovative life science offerings and enable us to provide more complete solutions to our customers.”

Over the past year, Kapa Biosystems has added several proven industry veterans to its management team and more than doubled the company’s previous facility investment to scale enzyme production, quality control, and manufacturing capacity across its various business franchises. Over the next few months, the company plans on announcing several other key distribution agreements and corporate initiatives to better support the growing number of customers around the world.

“With more than 25 years of experience working with cutting edge technologies and strong relationships with the key opinion leaders in Japan, Nippon Genetics is the ideal distribution partner for our business,” said Jean-Christophe Hatinguais, Director of International Sales, Kapa Biosystems. “We are seeing broad adoption and strong demand for our innovative products not only in Japan, but across the Asia Pacific, European, and North American regions. We are now focused on extending our global reach by increasing our strategic investments and expanding our distribution network in key markets.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Over Two-Thirds of Cervical Cancer Deaths Prevented
Cervical screening prevents 70% of cervical cancer deaths and if all eligible women regularly attended screening this would rise to 83%.
Detecting Bacterial Infections in Newborns
Researchers tested an alternative way to diagnose bacterial infections in infants—by analyzing RNA biosignatures from a small blood sample.
Mechanisms of Parkinson’s Pathology
Defects that lead to cells’ failure to decommission faulty mitochondria cause nerve cells to die, triggering the symptoms of Parkinson’s disease.
Case for Liquid Biopsies Builds in Advanced Lung Cancer
Study addresses unmet need for better, non-invasive tests called out in recent "Moonshot" blue ribbon panel report
Genetic Misdiagnoses of Heart Condition
Analysis found several genetic variations previously linked with a heart condition were harmless, leading to condition misdiagnosis.
Opening Door to Oesophageal Cancer Targeted Treatments
Scientists have discovered that oesophageal cancer can be classified into three different subtypes.
Genetic Diversity of Enzymes Alters Metabolic Individuality
ToMMo scientists have shown that genetic polymorphisms, structural location of mutation and effect for phenotype correlate with each other.
IMM Uses Nanowizard® to Evaluate Cardiovascular Disease Risk
JPK Instruments reports on the use of their NanoWizard® AFM system at the Instituto de Medicina Molecular at the University of Lisbon.
$1M NIH Grant to Refine PCR Based Cancer Test
Researchers at Cornell University, Weill Cornell Medicine, the University of California, San Francisco, and the Infectious Diseases Institute in Kampala, Uganda, recieve a four-year, $1 million grant to hone technology for a quick, in-the-field diagnosis of Kaposi's sarcoma — a cancer frequently related to HIV infections.
Zika Reference Strain Sequenced
An international research team has sequenced a strain of Zika for use as a WHO reference strain.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!